Background. Previous studies have demonstrated a positive relationship between elevated blood lead (BPb) and blood pressure (BP), but few have additionally examined the role of dietary calcium. Methods. The cross-sectional relationship between BPb and BP and the possible protective influence of increased dietary calcium on that relationship was examined among 798 male participants in the Normative Aging Study (NAS), a cohort of older men with relatively low BPb levels.
have reportedly demonstrated a positive relationship between BPb and BP in the general population, 2 "" and as it has been pointed out, even in some settings where BPb levels were <30 mcg/dl.' 2 However, since most of the studies have been cross-sectional and some were unable to control for some important confounding variables, the causality of this relationship has not been universally accepted.
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In the second National Health and Nutrition Examination Survey (NHANES II), in which mean BPb was approximately 17 mcg/dl, 14 BPb was found to be significantly associated with increased diastolic (DBP) and systolic blood pressure (SBP) when focusing on men aged 40-59 years. 4 ' 3 ' 8 and further analyses supported a significant BPb-BP relationship across the age range 20-74 years. Numerous factors may affect the role of lead in the pathogenesis of hypertension. 1 It has been observed that BPb and dietary calcium intake are inversely correlated and that increased dietary calcium intake is significantly associated with lower blood pressures. 4 ' 15 Animal studies have shown that a low calcium diet enhances the effect of lead on BP 16 and reduces lead clearance. 17 However, in an intervention study by Morris et a/.
18 in which a 10 mcg/dl increase in BPb was found to be significantly related to a 5 mmHg increase in supine SBP in males and dietary calcium was found to be significantly (but inversely) associated with BP, dietary calcium did not affect the association of blood lead with BP.
The objective of this investigation was to evaluate the cross-sectional relationship between BPb, dietary calcium intake and BP in a study of male participants in the Normative Aging Study, 19 a longitudinal study of ageing among males who had been initially recruited from communities in the Greater Boston area without regard for previous lead exposure. Based on previous studies, it was hypothesized that increased levels in BPb among this community-exposed population would be related to increased DBP and SBP and that in subjects with lower calcium intake, the relationship would be enhanced. As most previous studies that have demonstrated a positive association between BP and BPb have involved workers or others <75 years old, the present investigation allowed the examination of whether the relationship differed across a group of older men some of whom were taking anti-hypertensive medications.
METHODS
The Normative Aging Study is a longitudinal study of ageing established by the Veterans Administration in 1961.
1920 Subjects with elevated BP at baseline (i.e. >140 mmHg for SBP or >90 mmHg for DBP) were excluded from the study. Participants were enrolled and received their first medical examination between 1963 and 1968. Subsequently, men have been re-evaluated at 3-5-year intervals. At each visit a detailed examination, including medical history, routine physical examination, laboratory tests and questionnaires was completed. For further description of the selection of the initial male participants, see Hu et al. 21 and Payton et al.
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Beginning in January 1987, each NAS participant completed the self-administered Semi-Quantitative Food Frequency Questionnaire (SFFQ). This questionnaire was developed in its initial form in 1978 for the purpose of classifying individuals by their intakes of 18 nutrients possibly related to heart disease or cancer. For each food a common portion size was specified, taking advantage of natural units such as glasses of milk or slices of bread whenever possible. Extensive information on the construction, reproducibility and validity of the food frequency questionnaire has been published elsewhere. 23 ' 24 Specific validation of the SFFQ with respect to dietary calcium intake has been assessed by comparing the questionnaire responses to daily diet records. In a study of 27 men and women aged 20-54, the estimate of mean calcium intake by the SFFQ was within 2.2% of the mean calcium intake estimate derived from a one-year record completed 18 months earlier. 25 The correlation coefficient comparing unadjusted calcium intake measured by the two methods was 0.63. Among a separate group of 150 women, the correlation between calcium intake by the SFFQ and calcium intake as estimated by four one-week diet records was 0.56. 26 For this study, analysis was on 798 males for whom BPb was measured by flameless atomic absorption (graphite furnace, GF-AAS) and who had complete data on BPb, age, BP, dietary calcium, haematocrit, sitting heart rate, alcohol intake, body mass index (weight/ height 2 ), kilocalories expended during exercise, smoking status and anti-hypertensive medication status. About half the BPb values (n = 410) were determined from frozen red blood cells which were thawed and measured by GF-AAS; these samples were collected from those subjects who had bone lead measurements done between 1991 and 1993. The remainder of BPb samples were measured from fresh blood samples drawn from those NAS subjects seen between 1992 and 1993.
Measurements
For each examination visit, participants reported to the study centre at 8 a.m. after an overnight fast and abstinence from smoking. At this time blood specimens were obtained, including those for BPb measurement.
For 388 subjects, fresh whole blood samples were used to measure BPb. At the time of each participant's visit 7 ml of venous blood were collected in a trace metal-free tube containing EDTA and subsequently analysed by Zeeman background-corrected flameless atomic absorption (graphite furnace) at ESA Laboratories, Inc., Bedford, MA. This instrument was calibrated prior to use using National Bureau of Standard Lead Standard Materials and was rechecked after every 21 samples. In tests on reference samples from the Centers for Disease Control, precisions (% RSD) ranged from 8% for concentrations <30 mcg/dl to 1% for higher concentrations. In comparison to a National Bureau of Standard target of 5.7 mcg/dl, 24 measurements by this method gave a mean of 5.3 mcg/dl with a standard deviation of 1.23. The minimum detection limit of the instrument is 1 mcg/dl. All reported values of <1 mcg/dl were recoded as 0.5 mcg/dl.
For 410 subjects, frozen packed red blood cells (RBC) were analysed to determine whole BPb levels. Samples were pulled from freezers in stages and allowed to reach room temperature. An aliquot was subsequently centrifuged and the supernatant drawn off and analysed by the same GF-AAS technique described above. Results were initially recorded in meg of lead/dl packed RBC (RBC-Pb) and then transformed into meg lead/dl whole blood (BPb) using the formula: BPb = RBC-Pb x Hct/100, in which Hct represents the subject's haematocrit at time of blood drawing. Since 99% of BPb is attached to RBC, 27 this is an accurate technique for estimating whole BPb levels using archived specimens.
Blood pressure. This was measured by the examining physician using a standard mercury sphygmomanometer (Baumanometer; WA Baum Co., Inc., Copiage, New York) with a 14-cm cuff while the subject was seated. SBP and fifth-phase DBP were measured once in each arm to the nearest 2 mmHg, and the average of the right and left arm values was used in these analyses.
Dietary calcium. Intake of dietary calcium was defined by responses to the SFFQ. For regression analyses, dietary calcium was adjusted for total calorie intake by computing residuals from the regression of crude calcium intake on total calorie intake and adding the expected calcium value for the mean calorie intake. 23 The dietary calcium measure included calcium from supplement intake.
Anti-hypertensive medication status. This information was obtained from the self-administered medical history questionnaire and the medical history completed by the examining physician at the time of the study visit. A subject was considered to be on anti-hypertensive medication (AHM) if he was taking a diuretic, centrally acting hypotensive agent, vascular smooth muscle relaxant, angiotensin-converting enzyme blocker, beta blocker, or calcium channel blocker on a daily basis.
Body mass index (BMI).
This was calculated from the weight and height measurements collected at the time of the participant's visit [BMI = weight (kg)/height (m 2 )].
Physical activity or exercise. As an indication of the amount of physical activity or exercise, the kilocalories expended/week doing exercise were calculated from responses to questions in the SFFQ which pertained to the frequency and type of physical activity according to the Paffenberger scale. 28 In addition to considering the contribution from fast walking, this variable included a determination of the weekly energy expended in climbing stairs, regular walking, jogging, biking, running, swimming, calisthenics, tennis and/or playing ball.
Cigarette smoking. Information about cigarette smoking status was obtained from an interview during the study visit. Smoking status was defined as one of three categories: never smoker, current smoker (at least one cigarette/day), or former smoker (no smoking for at least 30 days prior to the visit).
Alcohol ingestion. Intake of beer, wine and hard liquor was recorded as the grams of alcohol ingested/day as derived from the data in the SFFQ.
Sitting heart rate (beats/min). This was measured by the examining physician during the physical examination.
Haematocrit. Measurement of haematocrit (%) was done at the VA Outpatient Clinic Laboratory on blood samples taken during the NAS visit.
Data Analysis
Univariate statistics were calculated for all variables of interest. Non-parametric smoothing graphics were used to explore the relationships between BPb and BP and other covariates of interest. 29 Pearson's product moment correlations were calculated between BPb, DBP and SBP, age, BMI, adjusted dietary calcium intake, haematocrit, sitting heart rate, alcohol intake, and kilocalories expended during exercise. Correlation matrices were done for the cohort as a whole and for men not on AHM. Bonferroni correction (P < 0.001) was applied when determining significance of correlations. Analysis of variance (ANOVA) was used to explore initially whether increased BPb (>I5 mcg/dl) was related to increased BP; and, if in men with lower adjusted calcium intake (^800 mg/day), the relationship was enhanced. The Recommended Dietary Allowance for adult males is 800 mg calcium/day. 30 In multivariate linear regression analyses, DBP and SBP measures were analysed as continuous outcome variables. The regression model where BPb entered as a continuous log-transformed variable was considered. Previous studies 4 ' 8 have observed a significant association between continuous BPb and BP and noted the appropriateness of this transformation. Before log transformation, 0.5 was added to the BPb values coded as 0.5 mcg/dl (i.e. those below the minimum detection limit). The covariates age, age 2 , BMI, adjusted dietary calcium, sitting heart rate, alcohol intake, haematocrit, smoking status, and exercise were forced into the models for cohort overall, for those not on AHM, and for those =£74 or >74 years old. 31 An age squared term was included to account for the curvilinear relationship between age and BP across a wide age range. When considering whether there was evidence of interaction between dietary calcium and BPb, the calcium x BPb interaction term was forced into the models. Variables were considered based on information from previous studies about possible confounders of the relationship of BPb, BP, and dietary calcium. Table 1 lists the means (medians where appropriate), standard deviation and range of the considered variables in this study population. Of this population, 85% had BPb values <10 mcg/dl; 1% were below the detection limit. Around 4% (n = 34) had BPb levels >15 mcg/dl. Around 1% had BPb levels >20 mcg/dl. Only one person had a BPb level >30 mcg/dl. The mean age of the male participants was 66.1 years; 22% were <60 years old and 15% were >74 years old. The mean SBP/DBP blood pressure was 133.7/80.1 mmHg. The mean BPb for the 334 men with ingestion of «800 mg of adjusted calcium per day was 6.7 mcg/dl. This was higher than the mean for those who ingested >800 mg/day (6.2; t = 1.9, P = 0.06).
RESULTS
Almost 28% of the 798 subjects (n = 223) were taking anti-hypertensive medication at the time of the examination. The mean BPb was lower in those taking AHM compared to those not on medication (6.1 compared to 6.7 mcg/dl; t = 1.8, P = 0.08). Approximately 10% (n = 76) of the group reported BP >90/140 mmHg (as a classification of hypertension status); and they had significantly higher mean BPb levels than the rest of the sample (7.7 compared to 6.4 mcg/dl; t = -2.7, P = 0.007).
Non-parametric smoothing graphics detected no obvious trend that indicated increased In BPb levels were related to increased SBP for the cohort overall. However, a subtle positive relationship was observed for DBP.
Pearson's product moment correlations for the cohort overall indicated that In BPb was positively related to BP, but the correlation was not significant. Ln BPb was negatively correlated with adjusted dietary calcium and exercise and positively correlated with haematocrit, sitting heart rate, and alcohol intake, although only the positive correlations were significant with the Bonferroni correction applied (P < 0.001). Adjusted dietary calcium was negatively correlated with both DBP and SBP; however, these relationships did not attain significance. Systolic blood pressure was significantly and positively correlated with age and BMI. Diastolic blood pressure was significantly and negatively correlated with age but significantly and positively correlated with BMI, haematocrit and sitting heart rate. Similar findings were observed when the analyses were restricted to those not taking anti-hypertensive medications (Table 2) . Table 3 presents the linear regression models examining the relationship of In BPb to DBP and SBP. Ln BPb was significantly related to DBP but not SBP in these models. Adjusted calcium was significantly associated with decreased SBP. When analyses were performed on the group data for those not on AHM, neither ln BPb nor adjusted calcium were significantly associated with either DBP or SBP (Table 4) .
For the cohort as a whole, neither mean DBP nor mean SBP was significantly lower for those men whose adjusted dietary calcium was >800 mg/day compared to those ingesting =s800 mg/day, nor was there any observed difference in that relationship between men with blood lead levels >15 mcg/dl (compared to =315 mcg/dl), which suggested that an interaction between BPb and dietary calcium on DBP did not exist at BPb levels >15 mcg/dl. Indeed, no evidence of interaction was observed in multivariate regression models.
Most positive studies carried out to date have included subjects younger than 75 years old. The present investigation provided an opportunity to test whether the BPb-BP relationship differed across an older age group; in this case, to examine whether the magnitude of the relationship between ln BPb and DBP and SBP was greater in those <75 years old. Linear regression analyses (with the covariates described above) were rerun with those subjects €74 years (n = 681) and ln BPb was significantly associated with an increase of 1.6 mmHg in DBP (95% CI: 0.42, 2.7; P = 0.007). No significant relationship between SBP and ln BPb nor between BP and adjusted calcium was observed however (Table 4) . When the same analyses were run for the group =574 years who were not on anti-hypertensive medications, ln BPb was not significantly associated with increased DBP nor SBP.
DISCUSSION
In this cohort of older men, when analysed as a single group, DBP was found to be significantly associated with ln BPb and adjusted calcium was associated with decreased SBP after controlling for important covariates, but there was no evidence of interaction with dietary calcium. When men receiving AHM were excluded from the analyses, the significant associations between ln BPb and DBP and adjusted calcium and SBP were no longer observed.
Some authors have postulated that the positive relationship between BPb and BP depends on the presence of a percentage of individuals with BPb levels >30 mcg/dl. 18 In fact, several negative studies have been reported in populations where BPb levels have been of similar distribution to that in this study (i.e. =£35 mcg/dl). 32 -33 In the study by Sharp et a/. 34 where BPb ranged from 2 to 21 mcg/dl, a significant inverse relation between SBP and BPb in non-black males (-5.71 mmHg/ln mcg/dl) was observed. Positive studies where the blood levels have been comparable to this study have been reported; but the relationship was observed only in blacks, 34 and only in women 13 after adjustment for important covariates. This study provides some support for the conclusion that the relationship does exist across relatively low BPb levels, but does not allow the examination of racial differences. This study differs from others not only by the low mean BPb, but also by the age distribution of the study population. Most of the prior studies have studied younger populations (i.e. up to 75 years old). 3 " 6 ' 8 " 10 -13 ' 35 This is the first investigation of the effects of low level BPb on BP in middle to older age groups (i.e. 43-90 years) and it suggests that the magnitude of the relationship may be diminished over an older age range. Increased dietary calcium has been associated with lower SBP in both males and females 3 * and lower SBP and DBP in females. 37 In this study after adjusting for covariates, dietary calcium adjusted for total calories was inversely associated with SBP, but the relationship did not hold when analysing those not on antihypertensive medications. Compared to the NHANES II study 37 however, both the mean total calories and dietary calcium intake were lower in this study (approximately 1000 kcal/day and 100 mg/day lower, respectively). This may be due to the older age of our population overall compared to that of NHANES II.
Most studies on the effect of BPb and BP to date have concluded that the results are the same regardless of whether or not participants were under treatment for hypertension at the time of the study, and thus have reported the results of all participants.
8 ' 13 Studies examining dietary factors and hypertension have excluded those with a history of hypertension or who are on antihypertensive medications. 35 " 38 Consideration of the potential for bias due to anti-hypertensive medication status and type of medication should be made in future studies of BPb and BP and dietary factors.
Measurement error may have contributed to a less efficient estimation of the potential association between BPb and BP. In this study, BPb was recorded to the nearest 2 mmHg in a standardized clinical procedure that required measurement in both arms while sitting (after a period of rest) and then averaging the measurements. No studies on the reliability of BP measurements in the NAS have been performed, so it is not possible to determine the amount of measurement error attributed to BP. However, even with a conservative estimate of 10% variability in BP measurements, there was adequate power in this study to detect a significant effect between ln BPb and BP. This study's findings of a relationship of lead with DBP, but not SBP, is somewhat unusual for lead-blood pressure studies. Most h»ve tended to find relationships of lead with SBP that are stronger than those with DBP.f 9 However, our subjects were older than the subjects of most of these studies, and older subjects have a much higher prevalence of SBP blood pressure elevations. 40 Such elevations are usually attributed to structural hardening of the arterial walls, which may also render SBP less responsive to the hypertensive effects of lead.
Blood lead is a measure of recent exposure in the past several months. Thus, BPb may be an imprecise measure of the body burden of lead in terms of its biological effect on BP; since, as has been shown in rats, chronic lead exposure affects BP, even at low level doses. 1 It is possible that lead's effect on BP in humans is due to the cumulative effect of exposure to lead. Bone lead levels, which remain elevated for decades, 41 may be more predictive of BP changes. Bone lead measurements on this cohort were started in 1991. Studies are now in progress to examine the relationship of both bone and BPb levels to BP and the development of hypertension using the recently developed technique of K-x-ray fluorescence to measure bone lead levels. 42 In conclusion, these data suggest that, for a relatively elderly population of men with low blood levels, BPb is associated with elevated DBP, however, the data also suggest that, among younger subjects in this study, the magnitude of the association may be higher. Future studies should be directed at examining the potential existence of confounding by anti-hypertensive medication status, as well as the potential modifying effect of age on the BPb-BP relationship.
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